Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Globalstar Reports Strong Sales Growth and Positive Outlook for Fiscal Year 2024

Elaine Mendonca by Elaine Mendonca
February 29, 2024
in Breaking News
0
Telecommunications Industry Stock Exchange
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

Globalstar, Inc. announced a significant 27% increase in sales for the fourth quarter of fiscal 2023, totaling $52.4 million. While slightly below expectations, the growth was driven by a rise in service revenue. The company’s adjusted EBITDA rose by 37% to $25.1 million, although there was a net loss of $(15.08) million. Looking forward to fiscal year 2024, Globalstar projects revenue between $225 million and $250 million with an adjusted EBITDA margin of approximately 50%. Recent achievements include securing contracts for XCOM RAN wireless systems with a government services company and a major US retailer. Despite a drop in stock price following the results, Globalstar remains positive about its expansion in satellite services.

GSAT Stock Price Soars on February 28, 2024: A Promising Trend for Investors

On February 28, 2024, GSAT stock closed at $1.74, marking a $0.08 increase since the previous market close, representing a 4.82% rise in the stock price. In after-hours trading, the stock continued to climb, rising an additional $0.04. GSAT is currently trading in the middle of its 52-week range and is above its 200-day simple moving average, indicating strength in its long-term trend. The stock’s upward trajectory on February 28th suggests growing interest and confidence in the company among market participants. Stock prices can be volatile and subject to fluctuations based on various factors. Investors should conduct their own research and consider their risk tolerance before making any investment decisions. Overall, the performance of GSAT stock on February 28, 2024, reflects a positive trend with a notable increase in price and potential opportunities for investors.

GSAT Stock Reports Mixed Performance in Financial Results: Revenue Up, Net Income Down

On February 28, 2024, GSAT stock experienced a mixed performance as the company reported its financial results for the past year and the third quarter. According to data from CNN Money, GSAT’s total revenue for the past year was $148.50 million, showing a 19.48% increase compared to the previous year. However, the total revenue for the third quarter was $57.68 million, indicating a 4.74% increase from the previous quarter.

Despite the increase in total revenue, GSAT reported a net income of -$256.92 million for the past year, marking a significant decrease of 128.12% compared to the previous year. The net income for the third quarter was -$6.17 million, representing a staggering decrease of 68644.44% from the previous quarter.

Additionally, the earnings per share (EPS) for GSAT were reported at -$0.14 for the past year, reflecting a decrease of 123.67% compared to the previous year. The EPS for the third quarter was -$0.00, showing a decrease of 242.86% from the previous quarter.

Overall, the financial results for GSAT on February 28, 2024, painted a mixed picture for investors. While the company saw an increase in total revenue, the significant decrease in net income and EPS raises concerns about the company’s profitability and financial health. Investors should closely monitor GSAT’s performance in the coming quarters to assess its long-term growth prospects and make informed investment decisions.

Tags: GSAT
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finances

BMO Capital Analyst Updates Price Target for International Money Express

Finance_ projections

Navigating Market Volatility The Role of Circuit Breakers in Financial Stability

Pharmaceutical Trading online

Strategic Sales Agreement Between VTV Therapeutics Inc and Cowen and Company

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com